Stacey Gundry
Concepts (358)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Transplantation | 63 | 2000 | 654 | 1.700 |
Why?
| Transplantation, Heterologous | 19 | 2000 | 192 | 0.830 |
Why?
| Heart Arrest, Induced | 8 | 1998 | 30 | 0.590 |
Why?
| Graft Rejection | 30 | 2000 | 536 | 0.510 |
Why?
| Tissue Donors | 11 | 1997 | 325 | 0.460 |
Why?
| Myocardial Reperfusion | 3 | 1995 | 51 | 0.350 |
Why?
| Heart Defects, Congenital | 16 | 2000 | 691 | 0.350 |
Why?
| Coronary Disease | 5 | 1998 | 352 | 0.310 |
Why?
| Pericardium | 3 | 1997 | 49 | 0.310 |
Why?
| Esophageal Perforation | 2 | 1996 | 9 | 0.270 |
Why?
| Graft Survival | 14 | 2000 | 486 | 0.270 |
Why?
| Heart Valve Prosthesis | 4 | 1997 | 122 | 0.250 |
Why?
| Coronary Artery Bypass | 3 | 1998 | 201 | 0.250 |
Why?
| Coronary Vessels | 4 | 1997 | 228 | 0.230 |
Why?
| Cardiac Catheterization | 4 | 1998 | 532 | 0.210 |
Why?
| Echocardiography | 9 | 1998 | 550 | 0.210 |
Why?
| Postoperative Complications | 18 | 2000 | 2180 | 0.210 |
Why?
| Infant | 43 | 2000 | 8119 | 0.200 |
Why?
| Cardiopulmonary Bypass | 6 | 1998 | 183 | 0.200 |
Why?
| Cardiac Surgical Procedures | 6 | 2000 | 434 | 0.200 |
Why?
| Sternum | 2 | 1998 | 14 | 0.190 |
Why?
| Infant, Newborn | 36 | 2000 | 5169 | 0.190 |
Why?
| Papio | 16 | 2000 | 92 | 0.190 |
Why?
| Zebrafish | 3 | 2018 | 419 | 0.190 |
Why?
| Reoperation | 11 | 1998 | 535 | 0.190 |
Why?
| Iatrogenic Disease | 2 | 1997 | 49 | 0.180 |
Why?
| Aortic Valve | 3 | 1998 | 351 | 0.170 |
Why?
| Graft Occlusion, Vascular | 2 | 1998 | 35 | 0.170 |
Why?
| Cardioplegic Solutions | 3 | 1995 | 6 | 0.160 |
Why?
| Time Factors | 24 | 2000 | 6248 | 0.160 |
Why?
| Thoracotomy | 2 | 1998 | 69 | 0.160 |
Why?
| Immunosuppressive Agents | 13 | 2000 | 675 | 0.150 |
Why?
| DEAD-box RNA Helicases | 1 | 2018 | 56 | 0.150 |
Why?
| Microsurgery | 1 | 1998 | 63 | 0.150 |
Why?
| Echocardiography, Doppler, Color | 1 | 1997 | 38 | 0.150 |
Why?
| Methotrexate | 10 | 2000 | 228 | 0.150 |
Why?
| Ventricular Outflow Obstruction | 2 | 1996 | 35 | 0.150 |
Why?
| Child, Preschool | 30 | 2000 | 9289 | 0.150 |
Why?
| RNA, Ribosomal | 1 | 2018 | 158 | 0.150 |
Why?
| Tetralogy of Fallot | 2 | 1998 | 79 | 0.150 |
Why?
| Follow-Up Studies | 17 | 1998 | 4516 | 0.150 |
Why?
| Swine | 12 | 2000 | 708 | 0.150 |
Why?
| Coronary Circulation | 2 | 1996 | 117 | 0.140 |
Why?
| Pulmonary Valve | 2 | 1996 | 91 | 0.140 |
Why?
| Protein Biosynthesis | 1 | 2018 | 391 | 0.140 |
Why?
| Survival Rate | 12 | 2000 | 1681 | 0.130 |
Why?
| Fontan Procedure | 1 | 1997 | 154 | 0.130 |
Why?
| Fundoplication | 1 | 1995 | 52 | 0.130 |
Why?
| Organ Transplantation | 1 | 1997 | 162 | 0.130 |
Why?
| Myopathies, Structural, Congenital | 1 | 2013 | 6 | 0.120 |
Why?
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2013 | 8 | 0.120 |
Why?
| Lymphocyte Subsets | 4 | 1996 | 76 | 0.110 |
Why?
| Hypoplastic Left Heart Syndrome | 4 | 1998 | 112 | 0.110 |
Why?
| Zebrafish Proteins | 2 | 2018 | 249 | 0.110 |
Why?
| Humans | 70 | 2013 | 116809 | 0.110 |
Why?
| Splenectomy | 5 | 2000 | 54 | 0.110 |
Why?
| Muscle, Skeletal | 3 | 2018 | 1499 | 0.110 |
Why?
| Animals | 32 | 2018 | 32702 | 0.100 |
Why?
| Heart Ventricles | 4 | 2000 | 719 | 0.100 |
Why?
| Dystroglycans | 1 | 2011 | 7 | 0.100 |
Why?
| Heart Diseases | 3 | 1993 | 332 | 0.100 |
Why?
| Muscular Dystrophies | 1 | 2011 | 36 | 0.100 |
Why?
| Child | 28 | 2000 | 18804 | 0.090 |
Why?
| Tissue and Organ Procurement | 6 | 1997 | 237 | 0.090 |
Why?
| Macaca mulatta | 7 | 2000 | 135 | 0.090 |
Why?
| Animals, Newborn | 9 | 2000 | 797 | 0.080 |
Why?
| Cyclosporine | 10 | 2000 | 172 | 0.080 |
Why?
| Mutation, Missense | 1 | 2011 | 299 | 0.080 |
Why?
| Organ Preservation | 3 | 1993 | 64 | 0.080 |
Why?
| Heart Failure | 3 | 2000 | 1952 | 0.080 |
Why?
| Aorta, Thoracic | 3 | 2000 | 231 | 0.080 |
Why?
| Myocardium | 7 | 1998 | 944 | 0.080 |
Why?
| Endothelium, Vascular | 5 | 2000 | 872 | 0.080 |
Why?
| Proteins | 1 | 2013 | 930 | 0.070 |
Why?
| Mitral Valve | 2 | 1998 | 85 | 0.070 |
Why?
| Thoracic Injuries | 2 | 2000 | 54 | 0.070 |
Why?
| Aged | 10 | 2000 | 19362 | 0.070 |
Why?
| Survival Analysis | 9 | 1998 | 1246 | 0.070 |
Why?
| Tacrolimus | 5 | 1997 | 148 | 0.070 |
Why?
| Angioplasty, Balloon, Coronary | 2 | 1998 | 147 | 0.070 |
Why?
| Male | 33 | 2011 | 56636 | 0.070 |
Why?
| Hemodynamics | 6 | 2000 | 987 | 0.070 |
Why?
| Ventricular Function, Left | 5 | 1995 | 465 | 0.070 |
Why?
| Heart | 3 | 1995 | 617 | 0.060 |
Why?
| Goats | 7 | 2000 | 25 | 0.060 |
Why?
| Female | 32 | 2011 | 60542 | 0.060 |
Why?
| Wounds, Nonpenetrating | 2 | 2000 | 232 | 0.060 |
Why?
| Resuscitation | 2 | 1997 | 217 | 0.060 |
Why?
| Blood | 2 | 1995 | 96 | 0.060 |
Why?
| Transplantation, Homologous | 5 | 2000 | 407 | 0.060 |
Why?
| Hydrogen-Ion Concentration | 2 | 1996 | 521 | 0.060 |
Why?
| Equipment Design | 2 | 1998 | 514 | 0.060 |
Why?
| Retrospective Studies | 18 | 2000 | 12740 | 0.050 |
Why?
| Carbon Dioxide | 2 | 1996 | 216 | 0.050 |
Why?
| Cardiopulmonary Resuscitation | 3 | 1995 | 222 | 0.050 |
Why?
| Adolescent | 14 | 2000 | 18154 | 0.050 |
Why?
| Aorta | 3 | 2000 | 358 | 0.050 |
Why?
| Treatment Outcome | 9 | 2000 | 9212 | 0.050 |
Why?
| Sheep | 3 | 1993 | 763 | 0.050 |
Why?
| Mitral Valve Insufficiency | 3 | 1997 | 62 | 0.050 |
Why?
| Cause of Death | 4 | 1997 | 372 | 0.050 |
Why?
| Body Temperature | 2 | 1993 | 212 | 0.050 |
Why?
| Cardiomyopathies | 2 | 1997 | 296 | 0.050 |
Why?
| Incidence | 6 | 2000 | 2373 | 0.050 |
Why?
| Aged, 80 and over | 4 | 2000 | 6478 | 0.050 |
Why?
| Disease Models, Animal | 1 | 2011 | 3626 | 0.050 |
Why?
| Heart Atria | 2 | 1992 | 109 | 0.050 |
Why?
| Methylprednisolone | 6 | 2000 | 83 | 0.050 |
Why?
| Trisaccharides | 1 | 2000 | 1 | 0.050 |
Why?
| Antigens, Heterophile | 1 | 2000 | 4 | 0.050 |
Why?
| Antibodies, Heterophile | 1 | 2000 | 13 | 0.050 |
Why?
| Polytetrafluoroethylene | 1 | 2000 | 23 | 0.050 |
Why?
| Aortic Rupture | 1 | 2000 | 26 | 0.050 |
Why?
| Transplantation Chimera | 1 | 2000 | 51 | 0.050 |
Why?
| Adult | 10 | 2000 | 30930 | 0.050 |
Why?
| Antilymphocyte Serum | 5 | 2000 | 66 | 0.050 |
Why?
| Cell Line | 2 | 2018 | 2669 | 0.050 |
Why?
| Oxygen | 2 | 1996 | 834 | 0.040 |
Why?
| Ambulatory Surgical Procedures | 1 | 2000 | 47 | 0.040 |
Why?
| Length of Stay | 2 | 1998 | 995 | 0.040 |
Why?
| Feasibility Studies | 3 | 1998 | 737 | 0.040 |
Why?
| Lymphocyte Activation | 2 | 2000 | 1063 | 0.040 |
Why?
| Myocardial Contraction | 4 | 1993 | 327 | 0.040 |
Why?
| Echocardiography, Transesophageal | 2 | 1997 | 86 | 0.040 |
Why?
| Rhizopus | 1 | 1999 | 5 | 0.040 |
Why?
| Lung Abscess | 1 | 1999 | 6 | 0.040 |
Why?
| Lung Diseases, Fungal | 1 | 1999 | 14 | 0.040 |
Why?
| Middle Aged | 9 | 2000 | 27140 | 0.040 |
Why?
| Mucormycosis | 1 | 1999 | 20 | 0.040 |
Why?
| Bone Marrow Transplantation | 1 | 2000 | 244 | 0.040 |
Why?
| Hypothermia, Induced | 2 | 1998 | 65 | 0.040 |
Why?
| Cell Adhesion | 1 | 2000 | 428 | 0.040 |
Why?
| Situs Inversus | 1 | 1998 | 3 | 0.040 |
Why?
| Lymphocytes | 1 | 2000 | 341 | 0.040 |
Why?
| Hospital Mortality | 3 | 2000 | 798 | 0.040 |
Why?
| Age Factors | 6 | 1995 | 2955 | 0.040 |
Why?
| PAX2 Transcription Factor | 1 | 2018 | 6 | 0.040 |
Why?
| Cell Nucleolus | 1 | 2018 | 17 | 0.040 |
Why?
| Dermatologic Surgical Procedures | 1 | 1998 | 19 | 0.040 |
Why?
| Suction | 1 | 1998 | 31 | 0.040 |
Why?
| Heart Septal Defects | 1 | 1997 | 10 | 0.040 |
Why?
| Aortic Coarctation | 1 | 1998 | 57 | 0.040 |
Why?
| Heart Septal Defects, Ventricular | 1 | 1998 | 43 | 0.040 |
Why?
| Heart Septal Defects, Atrial | 1 | 1998 | 50 | 0.040 |
Why?
| Death | 1 | 1998 | 104 | 0.040 |
Why?
| Drainage | 1 | 1998 | 151 | 0.040 |
Why?
| Muscle Development | 1 | 2018 | 102 | 0.040 |
Why?
| Myoblasts | 1 | 2018 | 74 | 0.040 |
Why?
| Aortic Valve Insufficiency | 1 | 1997 | 41 | 0.040 |
Why?
| Embryo, Nonmammalian | 1 | 2018 | 174 | 0.040 |
Why?
| Animals, Genetically Modified | 1 | 2018 | 221 | 0.040 |
Why?
| Vena Cava, Inferior | 1 | 1997 | 54 | 0.040 |
Why?
| Azathioprine | 5 | 1998 | 51 | 0.040 |
Why?
| United Kingdom | 1 | 1997 | 233 | 0.040 |
Why?
| Cardiomyopathy, Dilated | 1 | 2000 | 342 | 0.040 |
Why?
| Actuarial Analysis | 5 | 1996 | 22 | 0.040 |
Why?
| Minimally Invasive Surgical Procedures | 1 | 1998 | 156 | 0.040 |
Why?
| Patient Care Planning | 1 | 1997 | 142 | 0.040 |
Why?
| Ethics, Medical | 1 | 1997 | 70 | 0.040 |
Why?
| Regeneration | 1 | 2018 | 163 | 0.030 |
Why?
| Surgical Flaps | 1 | 1997 | 118 | 0.030 |
Why?
| Myosins | 2 | 1993 | 129 | 0.030 |
Why?
| Gastric Fundus | 1 | 1996 | 3 | 0.030 |
Why?
| Drug Therapy, Combination | 4 | 2000 | 960 | 0.030 |
Why?
| Intubation, Intratracheal | 1 | 1998 | 221 | 0.030 |
Why?
| Antibodies | 2 | 1997 | 378 | 0.030 |
Why?
| Brain Death | 2 | 1993 | 27 | 0.030 |
Why?
| Heart Valve Prosthesis Implantation | 1 | 1998 | 177 | 0.030 |
Why?
| T-Lymphocytes | 2 | 2000 | 1769 | 0.030 |
Why?
| Blood Pressure | 2 | 1993 | 1633 | 0.030 |
Why?
| Morbidity | 1 | 1996 | 285 | 0.030 |
Why?
| Heart-Assist Devices | 1 | 2000 | 481 | 0.030 |
Why?
| Pulmonary Veins | 1 | 1995 | 84 | 0.030 |
Why?
| Research | 1 | 1997 | 402 | 0.030 |
Why?
| Arteriosclerosis | 1 | 1994 | 86 | 0.030 |
Why?
| Persistent Fetal Circulation Syndrome | 1 | 1995 | 132 | 0.030 |
Why?
| Patient Satisfaction | 1 | 1998 | 599 | 0.030 |
Why?
| Central Nervous System | 1 | 1996 | 242 | 0.030 |
Why?
| Bioprosthesis | 1 | 1994 | 36 | 0.030 |
Why?
| Societies, Medical | 1 | 1997 | 680 | 0.030 |
Why?
| Myosin Light Chains | 1 | 1993 | 34 | 0.030 |
Why?
| Blood Gas Analysis | 1 | 1993 | 68 | 0.030 |
Why?
| Aneurysm, False | 1 | 1993 | 44 | 0.030 |
Why?
| Transplantation, Autologous | 1 | 1994 | 187 | 0.030 |
Why?
| Prosthesis Failure | 1 | 1994 | 118 | 0.030 |
Why?
| Interleukin-6 | 1 | 1997 | 678 | 0.030 |
Why?
| Clinical Trials as Topic | 1 | 1997 | 955 | 0.030 |
Why?
| Heart Septum | 1 | 1992 | 27 | 0.030 |
Why?
| Protein Stability | 1 | 2013 | 163 | 0.030 |
Why?
| Transposition of Great Vessels | 1 | 1992 | 27 | 0.030 |
Why?
| California | 4 | 1997 | 369 | 0.030 |
Why?
| Syndrome | 2 | 1991 | 338 | 0.030 |
Why?
| Catalysis | 1 | 2013 | 281 | 0.030 |
Why?
| Body Weight | 2 | 1995 | 899 | 0.030 |
Why?
| Postoperative Care | 1 | 1993 | 226 | 0.030 |
Why?
| Aortic Aneurysm, Thoracic | 1 | 1993 | 116 | 0.030 |
Why?
| Muscles | 1 | 2013 | 331 | 0.030 |
Why?
| Pulmonary Artery | 1 | 1997 | 1022 | 0.030 |
Why?
| Defibrillators, Implantable | 1 | 1994 | 283 | 0.020 |
Why?
| Peritoneal Dialysis | 1 | 1992 | 84 | 0.020 |
Why?
| Cardiomegaly | 1 | 1992 | 166 | 0.020 |
Why?
| Cytomegalovirus Infections | 1 | 1993 | 185 | 0.020 |
Why?
| Myocardial Revascularization | 1 | 1990 | 68 | 0.020 |
Why?
| Cell Proliferation | 1 | 2018 | 2232 | 0.020 |
Why?
| Whole-Body Irradiation | 2 | 2000 | 72 | 0.020 |
Why?
| Point Mutation | 1 | 2011 | 225 | 0.020 |
Why?
| Temperature | 1 | 1993 | 609 | 0.020 |
Why?
| Decision Trees | 1 | 1990 | 82 | 0.020 |
Why?
| HLA Antigens | 1 | 1991 | 222 | 0.020 |
Why?
| Mice | 2 | 2018 | 15289 | 0.020 |
Why?
| Antibody Formation | 2 | 2000 | 275 | 0.020 |
Why?
| Lymphocyte Culture Test, Mixed | 2 | 2000 | 43 | 0.020 |
Why?
| Case-Control Studies | 1 | 1996 | 3120 | 0.020 |
Why?
| CD2 Antigens | 2 | 2000 | 5 | 0.020 |
Why?
| Palliative Care | 2 | 1994 | 626 | 0.020 |
Why?
| Mental Disorders | 1 | 1996 | 914 | 0.020 |
Why?
| Emergencies | 2 | 2000 | 151 | 0.020 |
Why?
| Base Sequence | 1 | 2011 | 2125 | 0.020 |
Why?
| Risk Factors | 6 | 1998 | 8865 | 0.020 |
Why?
| Guanidines | 2 | 1997 | 34 | 0.020 |
Why?
| Killer Cells, Natural | 2 | 2000 | 379 | 0.020 |
Why?
| Preoperative Care | 3 | 1994 | 326 | 0.020 |
Why?
| Immunoglobulin M | 2 | 2000 | 249 | 0.020 |
Why?
| Combined Modality Therapy | 2 | 2000 | 1156 | 0.020 |
Why?
| Leukocytes | 2 | 2000 | 282 | 0.020 |
Why?
| United States | 3 | 1997 | 12337 | 0.020 |
Why?
| Molecular Sequence Data | 1 | 2011 | 2820 | 0.020 |
Why?
| Motor Activity | 1 | 2011 | 650 | 0.020 |
Why?
| Cryopreservation | 2 | 1997 | 95 | 0.020 |
Why?
| Antigens, CD | 2 | 2000 | 451 | 0.020 |
Why?
| Acute Kidney Injury | 1 | 1992 | 698 | 0.020 |
Why?
| Myocardial Ischemia | 2 | 1999 | 242 | 0.020 |
Why?
| Forecasting | 2 | 1998 | 338 | 0.020 |
Why?
| Hemorrhage | 2 | 2000 | 601 | 0.020 |
Why?
| Recurrence | 2 | 1998 | 960 | 0.010 |
Why?
| Contraindications | 2 | 1993 | 85 | 0.010 |
Why?
| Pediatrics | 1 | 1991 | 972 | 0.010 |
Why?
| Prognosis | 3 | 2000 | 3384 | 0.010 |
Why?
| Chi-Square Distribution | 2 | 1995 | 516 | 0.010 |
Why?
| CD8 Antigens | 2 | 1994 | 70 | 0.010 |
Why?
| Hypertension, Pulmonary | 1 | 1994 | 1771 | 0.010 |
Why?
| CD4 Antigens | 2 | 1994 | 125 | 0.010 |
Why?
| Stroke Volume | 2 | 1995 | 510 | 0.010 |
Why?
| Mutation | 1 | 2013 | 3408 | 0.010 |
Why?
| Cells, Cultured | 2 | 2000 | 3962 | 0.010 |
Why?
| Cytokines | 2 | 2000 | 1855 | 0.010 |
Why?
| Pokeweed Mitogens | 1 | 2000 | 6 | 0.010 |
Why?
| Extracorporeal Circulation | 1 | 2000 | 13 | 0.010 |
Why?
| Constriction | 1 | 2000 | 44 | 0.010 |
Why?
| Paraplegia | 1 | 2000 | 51 | 0.010 |
Why?
| T-Lymphocyte Subsets | 2 | 1992 | 392 | 0.010 |
Why?
| Amphotericin B | 1 | 1999 | 30 | 0.010 |
Why?
| Biopsy | 2 | 1994 | 1059 | 0.010 |
Why?
| Elective Surgical Procedures | 1 | 2000 | 157 | 0.010 |
Why?
| Prospective Studies | 3 | 1996 | 6371 | 0.010 |
Why?
| Fetal Blood | 1 | 2000 | 270 | 0.010 |
Why?
| Lymphatic Irradiation | 1 | 1998 | 9 | 0.010 |
Why?
| Spleen | 1 | 2000 | 491 | 0.010 |
Why?
| Regional Blood Flow | 1 | 2000 | 416 | 0.010 |
Why?
| Immunity, Cellular | 1 | 2000 | 267 | 0.010 |
Why?
| In Vitro Techniques | 1 | 2000 | 1057 | 0.010 |
Why?
| Antifungal Agents | 1 | 1999 | 133 | 0.010 |
Why?
| Epitopes | 1 | 2000 | 438 | 0.010 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 804 | 0.010 |
Why?
| Immunoglobulins | 1 | 1998 | 150 | 0.010 |
Why?
| Cattle | 1 | 2000 | 955 | 0.010 |
Why?
| Angioplasty, Balloon | 1 | 1998 | 88 | 0.010 |
Why?
| Euthanasia, Passive | 1 | 1997 | 2 | 0.010 |
Why?
| Death, Sudden, Cardiac | 1 | 1998 | 155 | 0.010 |
Why?
| Swine, Miniature | 1 | 1997 | 70 | 0.010 |
Why?
| Perfusion | 1 | 1997 | 146 | 0.010 |
Why?
| Disease-Free Survival | 1 | 1998 | 643 | 0.010 |
Why?
| Withholding Treatment | 1 | 1997 | 67 | 0.010 |
Why?
| Safety | 1 | 1998 | 298 | 0.010 |
Why?
| Random Allocation | 1 | 1997 | 339 | 0.010 |
Why?
| Pressure | 1 | 1997 | 225 | 0.010 |
Why?
| Immunoglobulin G | 1 | 2000 | 784 | 0.010 |
Why?
| Ultrasonography | 1 | 2000 | 664 | 0.010 |
Why?
| Disclosure | 1 | 1997 | 102 | 0.010 |
Why?
| Fetus | 1 | 2000 | 689 | 0.010 |
Why?
| Antigens, Differentiation | 1 | 1996 | 79 | 0.010 |
Why?
| Body Surface Area | 1 | 1995 | 28 | 0.010 |
Why?
| Informed Consent | 1 | 1997 | 162 | 0.010 |
Why?
| Cadaver | 1 | 1997 | 307 | 0.010 |
Why?
| Linear Models | 1 | 1998 | 809 | 0.010 |
Why?
| Cyclophosphamide | 1 | 1996 | 221 | 0.010 |
Why?
| Pulmonary Veno-Occlusive Disease | 1 | 1995 | 10 | 0.010 |
Why?
| Edema | 1 | 1996 | 122 | 0.010 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2000 | 1138 | 0.010 |
Why?
| Necrosis | 1 | 1996 | 222 | 0.010 |
Why?
| Liver Function Tests | 1 | 1995 | 106 | 0.010 |
Why?
| Cardiac Output, Low | 1 | 1995 | 67 | 0.010 |
Why?
| Heart Valve Diseases | 1 | 1996 | 122 | 0.010 |
Why?
| Organ Size | 1 | 1995 | 458 | 0.010 |
Why?
| Leukocyte Count | 1 | 1995 | 297 | 0.010 |
Why?
| CD4-CD8 Ratio | 1 | 1994 | 19 | 0.010 |
Why?
| Antigens, CD20 | 1 | 1994 | 28 | 0.010 |
Why?
| Antigens, Differentiation, B-Lymphocyte | 1 | 1994 | 34 | 0.010 |
Why?
| Antigens, Differentiation, T-Lymphocyte | 1 | 1994 | 84 | 0.010 |
Why?
| Methods | 1 | 1994 | 62 | 0.010 |
Why?
| Shock | 1 | 1995 | 83 | 0.010 |
Why?
| Cardiac Volume | 1 | 1994 | 12 | 0.010 |
Why?
| Treatment Failure | 1 | 1995 | 337 | 0.010 |
Why?
| Pericardial Effusion | 1 | 1994 | 18 | 0.010 |
Why?
| Antigens, Surface | 1 | 1994 | 152 | 0.010 |
Why?
| Immunohistochemistry | 1 | 1998 | 1651 | 0.010 |
Why?
| Evaluation Studies as Topic | 1 | 1994 | 177 | 0.010 |
Why?
| Fluorescent Antibody Technique | 1 | 1994 | 400 | 0.010 |
Why?
| H-Y Antigen | 1 | 1993 | 8 | 0.010 |
Why?
| Drug Administration Schedule | 1 | 1995 | 726 | 0.010 |
Why?
| Histocompatibility | 1 | 1993 | 26 | 0.010 |
Why?
| Single-Blind Method | 1 | 1994 | 260 | 0.010 |
Why?
| Receptors, Immunologic | 1 | 1994 | 204 | 0.010 |
Why?
| Emergency Medical Services | 1 | 2000 | 585 | 0.010 |
Why?
| Graft vs Host Disease | 1 | 1995 | 214 | 0.010 |
Why?
| Pulmonary Atelectasis | 1 | 1992 | 12 | 0.010 |
Why?
| Cohort Studies | 2 | 1993 | 5047 | 0.010 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1996 | 267 | 0.010 |
Why?
| Myocarditis | 1 | 1994 | 91 | 0.010 |
Why?
| Diastole | 1 | 1993 | 142 | 0.010 |
Why?
| Regression Analysis | 1 | 1995 | 979 | 0.010 |
Why?
| Systole | 1 | 1993 | 166 | 0.010 |
Why?
| Ventricular Function | 1 | 1992 | 57 | 0.010 |
Why?
| Prednisone | 1 | 1993 | 233 | 0.010 |
Why?
| Monitoring, Physiologic | 1 | 1994 | 262 | 0.010 |
Why?
| Erythromycin | 1 | 1991 | 24 | 0.010 |
Why?
| Ciprofloxacin | 1 | 1991 | 23 | 0.010 |
Why?
| Gentamicins | 1 | 1991 | 42 | 0.010 |
Why?
| Confidence Intervals | 1 | 1992 | 316 | 0.010 |
Why?
| Transforming Growth Factor alpha | 1 | 1991 | 53 | 0.010 |
Why?
| Heart Arrest | 1 | 1995 | 286 | 0.010 |
Why?
| Platelet-Derived Growth Factor | 1 | 1991 | 82 | 0.010 |
Why?
| Multivariate Analysis | 1 | 1995 | 1458 | 0.010 |
Why?
| B-Lymphocyte Subsets | 1 | 1991 | 67 | 0.010 |
Why?
| Macrophages | 1 | 1998 | 1296 | 0.010 |
Why?
| Logistic Models | 1 | 1996 | 1876 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 1995 | 1893 | 0.010 |
Why?
| Drug Interactions | 1 | 1991 | 345 | 0.010 |
Why?
| Clinical Protocols | 1 | 1991 | 231 | 0.010 |
Why?
| Registries | 1 | 1997 | 1774 | 0.010 |
Why?
| Emergency Service, Hospital | 1 | 2000 | 1833 | 0.010 |
Why?
| Hypertension | 1 | 1998 | 1186 | 0.010 |
Why?
| Antibodies, Viral | 1 | 1993 | 537 | 0.010 |
Why?
| Sensitivity and Specificity | 1 | 1994 | 1754 | 0.010 |
Why?
| Communicable Diseases | 1 | 1991 | 131 | 0.010 |
Why?
| Erythrocytes | 1 | 1994 | 613 | 0.010 |
Why?
| Transforming Growth Factor beta | 1 | 1991 | 458 | 0.010 |
Why?
| Counseling | 1 | 1991 | 339 | 0.010 |
Why?
| Immunity, Innate | 1 | 1994 | 741 | 0.000 |
Why?
| Flow Cytometry | 1 | 1991 | 1066 | 0.000 |
Why?
| Analysis of Variance | 1 | 1991 | 1248 | 0.000 |
Why?
| Sex Factors | 1 | 1993 | 1749 | 0.000 |
Why?
| Biomarkers | 1 | 1997 | 3540 | 0.000 |
Why?
| Myocardial Infarction | 1 | 1993 | 956 | 0.000 |
Why?
| Quality of Life | 1 | 1996 | 2353 | 0.000 |
Why?
| Antibodies, Monoclonal | 1 | 1991 | 1271 | 0.000 |
Why?
| Mass Screening | 1 | 1991 | 1035 | 0.000 |
Why?
| Tomography, X-Ray Computed | 1 | 1993 | 2398 | 0.000 |
Why?
|
|
Gundry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|